HyperView™
4Pages

HyperView PRODUCT

The Leader in Hyperspectral Imaging for Tissue Oximetry Establishing a New Standard of Care A New Generation of Advanced Portable Imaging Has Arrived HyperMed Imaging, Inc. is the established leader in medical hyperspectral imaging for surface tissue oximetry. Our pioneering technology has over 10 years of established history in the market and has been shown in published clinical research to effectively assess oxyhemoglobin, deoxyhemoglobin and oxyhemoglobin saturation in superficial tissue for a number of key healthcare applications. HyperMed has developed a smaller, faster, and more...

HyperMed invites healthcare professionals and industry participants to contact us for more information Tissue viability in surgical and wound healing applications are dependent upon localized delivery of oxygen by the microcirculatory system. Existing diagnostic tools that represent standards of care for vascular assessment do not image the key biomarkers of interest in tissue, which are oxyhemoglobin and deoxyhemoglobin levels and oxygen saturation. For example, the Ankle Brachial Index (ABI) does not provide a measurement or image of hemoglobin levels or oxygen saturation. Doppler based...

HyperView uses visible light and an internal spectrometer to differentiate light absorption between oxygenated hemoglobin and deoxygenated hemoglobin. Results are presented as color-coded images containing quantitative data which depict levels of oxyhemoglobin and deoxyhemoglobin, as well as oxygen saturation values. Built-in software tools allow the clinician to analyze various areas within the image corresponding to locations on the skin surface. This allows the clinician to determine areas of ischemic tissue and visualize arterial and venous sufficiency in localized tissue, for example...